About Concentra Group Holdings Parent Inc
- Industry: Health Care
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://ir.concentra.com/
Frequently Asked Questions
What is the 52-week range for CON?
The 52-week high is $36.71 and the 52-week low is $18.545.
What is the P/E ratio for CON?
The Price to Earnings (P/E) ratio is 22.88.
What is the dividend yield for CON?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 47.30%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 8.69%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 6.41.
Analyst Recommendation Trends
Wall Street analyst consensus for CON over the last few months:
Latest CON News
CON or MEDP: Which Is the Better Value Stock Right Now?
CON vs. MEDP: Which Stock Is the Better Value Option?
Is Anika Therapeutics (ANIK) Outperforming Other Medical Stocks This Year?
Here is how Anika Therapeutics (ANIK) and Concentra Group (CON) have performed compared to their sector so far this year.
Nutex Health: The Stock Has Had A Great Run, But New Guidance Justifies A Higher Target Price (Rating Upgrade)
Nutex Health's profitability and growth metrics significantly outpace peers, driven by effective use of the No Surprises Act and disciplined cost controls. See why NUTX stock is a Buy.
Concentra Group Holdings Parent (CON) Beats Again And Expands In Florida, Is The Stock Still Undervalued?
Concentra Group Holdings Parent (CON) has drawn fresh attention after reporting another earnings beat in August 2026 and opening a new occupational health center in Daytona Beach, Florida, expanding its footprint in a regional hub. Those moves have landed against a strong run in the share price, with Concentra Group Holdings Parent now at US$36.37 and showing an 87.38% year to date share price return. The 1-year total shareholder return of 76.79% points to momentum that has been building...
Concentra Group Holdings Parent: Potential Beneficiary Of Increased Injuries From Data Center Capex
Concentra (CON) stock: BUY as shares surge 78% YTD. Learn why earnings beat, margin leverage, M&A pipeline and valuation discount may drive upside.
EQ's Concentra awards $150,000 to credit unions strengthening Canadian communities
Equitable Bank (EQ) today announced that its subsidiary Concentra has awarded $150,000 to six credit unions through its 2026 Empowering Your Community (EYC) program. A leading partner to the credit union system, Concentra provides trust and financial service solutions to Canadian credit unions and has awarded more than $2.3 million to credit unions and their partners since the program's inception in 2011.
Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?
Concentra (CON) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Concentra Expands Florida Footprint with New Daytona Beach Medical Center
DAYTONA BEACH, Fla., September 14, 2026--Concentra® (NYSE: CON), the nation's leader in occupational medicine and workforce health services, today announced the opening of its newest Florida medical center and first location in Volusia County. The Daytona Beach medical center expands access to occupational health services for employers and employees throughout the Greater Daytona region.
CON vs. MEDP: Which Stock Is the Better Value Option?
CON vs. MEDP: Which Stock Is the Better Value Option?
JP Morgan Maintains Overweight on Concentra Group Holdings, Raises Price Target to $43
JP Morgan analyst Benjamin Rossi maintains Concentra Group Holdings (NYSE:CON) with a Overweight and raises the price target from $34 to $43.
Are You Looking for a Top Momentum Pick? Why Concentra Group (CON) is a Great Choice
Does Concentra Group (CON) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are Medical Stocks Lagging CareDx (CDNA) This Year?
Here is how CareDx (CDNA) and Concentra Group (CON) have performed compared to their sector so far this year.
Concentra Appoints Tanner Newton Chief Financial Officer
DALLAS, September 08, 2026--Concentra® (NYSE: CON), the nation’s leader in occupational medicine and workforce health services, today announced that Tanner Newton, senior vice president of strategy and finance, has been appointed executive vice president and chief financial officer, effective Nov. 1, 2026.
Zacks.com featured highlights include Concentra, QuinStreet and Arrow Electronics
Broker rating upgrades spotlight Concentra, QuinStreet and Arrow Electronics, with earnings growth forecasts ranging from 16.8% to 92.7%.
3 Stocks to Add to Your Portfolio After Recent Broker Rating Upgrades
Concentra Group, QuinStreet and Arrow Electronics pair broker rating upgrades with strong projected earnings growth, making them stocks to consider.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-21 | ORTENZIO ROBERT A | -20,000 | $34.65 | $693,000 |
| 2026-08-21 | ORTENZIO ROBERT A | -30,000 | $34.65 | $1,039,500 |
| 2026-08-21 | ORTENZIO ROBERT A | -30,000 | $34.65 | $1,039,500 |
| 2026-08-21 | ORTENZIO ROBERT A | -150,000 | $34.65 | $5,197,500 |
| 2026-08-21 | ORTENZIO ROBERT A | -770,000 | $34.65 | $26,680,500 |
| 2026-08-21 | ORTENZIO ROBERT A | -20,000 | $34.65 | $693,000 |
| 2026-08-21 | ORTENZIO ROBERT A | -30,000 | $35.65 | $1,069,500 |
| 2026-08-21 | ORTENZIO ROBERT A | -30,000 | $34.65 | $1,039,500 |
| 2026-08-21 | ORTENZIO ROBERT A | -150,000 | $34.65 | $5,197,500 |
| 2026-08-21 | ORTENZIO ROBERT A | -770,000 | $34.65 | $26,680,500 |
| 2026-08-03 | ORTENZIO ROBERT A | -130,000 | $31.8412 | $4,139,356 |
| 2026-07-01 | ORTENZIO ROBERT A | -130,000 | $30.4969 | $3,964,597 |
| 2026-06-01 | ORTENZIO ROBERT A | -130,000 | $25.0002 | $3,250,026 |
| 2026-05-08 | ORTENZIO ROBERT A | -130,000 | $25 | $3,250,000 |
| 2025-12-17 | Newton William Keith | +89,081 | - | - |
| 2025-12-17 | Newton William Keith | -89,081 | - | - |
| 2025-11-26 | Ryan Timothy F. | -5,903 | $21.04 | $124,199 |
| 2025-11-26 | Anderson John Robert Jr. | -6,540 | $21.04 | $137,602 |
| 2025-11-26 | deLorimier John A. | -6,428 | $21.04 | $135,245 |
| 2025-11-26 | McAndrew Douglas R. | -5,903 | $21.04 | $124,199 |
| 2025-11-26 | Nelson Su Zan | -5,903 | $21.04 | $124,199 |
| 2025-11-26 | Devasia Thomas A. | -5,903 | $21.04 | $124,199 |
| 2025-11-26 | Gilbert Greg M. | -5,903 | $21.04 | $124,199 |
| 2025-11-26 | Rhine Michael D. | -3,935 | $21.04 | $82,792 |
| 2025-11-26 | Kendall Danielle | -3,935 | $21.04 | $82,792 |
| 2025-11-26 | DiCanio Matthew T. | -17,708 | $21.04 | $372,576 |
| 2025-11-26 | Conser Jonathan P. | -5,903 | $21.04 | $124,199 |
| 2025-11-26 | Gallara Giovanni | -6,563 | $21.04 | $138,086 |
| 2025-11-26 | Kosuth Michael A. | -6,449 | $21.04 | $135,687 |
| 2025-11-25 | ORTENZIO ROBERT A | -100,000 | - | - |
| 2025-11-04 | Rhine Michael D. | +40,000 | - | - |
| 2025-11-04 | Kosuth Michael A. | +60,000 | - | - |
| 2025-11-04 | DiCanio Matthew T. | +180,000 | - | - |
| 2025-11-04 | Gallara Giovanni | +60,000 | - | - |
| 2025-11-04 | Newton William Keith | +225,000 | - | - |
| 2025-11-04 | Ryan Timothy F. | +60,000 | - | - |
| 2025-11-04 | Gopal Vipin | +7,748 | - | - |
| 2025-11-04 | Gopal Vipin | +7,748 | - | - |
| 2025-11-04 | McAndrew Douglas R. | +60,000 | - | - |
| 2025-11-04 | ORTENZIO ROBERT A | +7,748 | - | - |
| 2025-11-04 | Devasia Thomas A. | +60,000 | - | - |
| 2025-11-04 | Kendall Danielle | +40,000 | - | - |
| 2025-11-04 | Nelson Su Zan | +60,000 | - | - |
| 2025-11-04 | Anderson John Robert Jr. | +60,000 | - | - |
| 2025-11-04 | Conser Jonathan P. | +60,000 | - | - |
| 2025-11-04 | deLorimier John A. | +60,000 | - | - |
| 2025-11-04 | Gilbert Greg M. | +60,000 | - | - |
| 2025-11-04 | Watkins Marc R. | +7,748 | - | - |
| 2025-11-04 | Thomas Daniel | +7,748 | - | - |
| 2025-11-04 | Pegus Cheryl | +7,748 | - | - |
| 2025-11-04 | Bonner Brigid A. | +7,748 | - | - |
| 2025-11-04 | Bonner Brigid A. | +7,748 | - | - |